Reverse Medical Corporation, an Irvine, CA-based has developer of patented technologies for both treating and preventing Acute Ischemic Strokes closed a $14m Series-B private equity financing from new investors Wexford Capital, Getz Bros., BioStar Ventures, Early Stage Partners and Emergent Medical Partners.
Current investors NBGI Ventures, MedFocus Funds and South Australian Life Science Advancement Partnership also participated in the round.
Reverse Medical has developed a microcatheter for performing thrombectomy.
The capital infusion will allow the company, which was founded and incubated by The MedFocus Fund, to continue its progress toward commercialization and profitability.
FinSMEs
30/03/2010